Effectiveness of Two Hyaluronic Acids in Osteoarthritis of the Knee
Single-blind Randomised Pragmatic Trial Comparing the Effectiveness of Two Hyaluronic Acid Viscosupplements, DUROLANE® (Single Injection) Versus HYALGAN® (Three Injections) for Symptomatic Tibiofemoral Osteoarthritis of the Knee.
Sponsor: Bioventus LLC
Terminated
post transfer of company ownership from Smith \& Nephew to Bioventus LLC
Other terminated trials from Bioventus LLC
- Knee Osteoarthritis · Phase NA · Aug 2014
- Tibial Fractures · Phase NA · Dec 2012
- Lumbar Degenerative Disc Disease · Phase NA · May 2012
More terminations from Bioventus LLC
This NA trial investigates Knee Osteoarthritis and is currently terminated or withdrawn. Bioventus LLC leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Terminated NA
First recorded
Feb 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bioventus LLC
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Argeles, France , Belfort, France , Billère, France , Cabestany, France , Cornebarrieu, France , Créteil, France , Lyon, France , Metz, France , Meulan-en-Yvelines, France , Monaco, Monaco and 6 more locations